EIR Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Damora TherapeuticsNASDAQ: DMRANov 2020SEC filingmedium confidence
Advancing potentially best-in-class therapeutics for myeloproliferative neoplasms.
BiotechCopenhagen, US
Garrett Winslow(Executive Officer)Lori Firmani(Executive Officer)Hans T. Schambye(Executive Officer, Director)
BoardChristopher Cain(Director)Carl Goldfischer(Director)Peter Harwin(Director)
Board seatStephan Christgau· per SEC Form D · $64.2M raise · filed Nov 2020
Co-investorsAccess BiotechnologyBay City Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.